Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation

Autor: Walid Soussou, Stuart A. Lipton, Scott R. McKercher, Sara Sanz-Blasco, Nima Dolatabadi, Mohd Waseem Akhtar, Rajesh Ambasudhan, Michelle S. Lee, James C. Parker, Tomohiro Nakamura, Kevin Chon
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Aging
Long-Term Potentiation
General Physics and Astronomy
Neurodegenerative
Alzheimer's Disease
Hippocampus
Insulysin
Transgenic
GTP Phosphohydrolases
Synapse
Mice
0302 clinical medicine
80 and over
Insulin
2.1 Biological and endogenous factors
Aetiology
Aged
80 and over

Cerebral Cortex
Neurons
Metabolic Syndrome
Multidisciplinary
Diabetes
Memantine
Brain
Long-term potentiation
Reactive Nitrogen Species
Neurological
NMDA receptor
Female
Mitochondrial fission
Alzheimer's disease
Microtubule-Associated Proteins
Type 2
Nitroso Compounds
medicine.drug
Dynamins
Adult
medicine.medical_specialty
Dendritic Spines
Science
Immunoblotting
Induced Pluripotent Stem Cells
Mice
Transgenic

Biology
Nitric Oxide
Article
General Biochemistry
Genetics and Molecular Biology

Mitochondrial Proteins
03 medical and health sciences
Oxygen Consumption
Alzheimer Disease
Internal medicine
Diabetes Mellitus
Acquired Cognitive Impairment
medicine
Animals
Humans
Metabolic and endocrine
Aged
Nutrition
Amyloid beta-Peptides
Animal
Neurosciences
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
General Chemistry
S-Nitrosylation
medicine.disease
Rats
Brain Disorders
Disease Models
Animal

Glucose
030104 developmental biology
Endocrinology
Diabetes Mellitus
Type 2

Hyperglycemia
Case-Control Studies
Synapses
Disease Models
Synaptic plasticity
Dementia
Excitatory Amino Acid Antagonists
030217 neurology & neurosurgery
Zdroj: Nature Communications, Vol 7, Iss 1, Pp 1-11 (2016)
Nature communications, vol 7, iss 1
Nature Communications
ISSN: 2041-1723
Popis: Metabolic syndrome (MetS) and Type 2 diabetes mellitus (T2DM) increase risk for Alzheimer's disease (AD). The molecular mechanism for this association remains poorly defined. Here we report in human and rodent tissues that elevated glucose, as found in MetS/T2DM, and oligomeric β-amyloid (Aβ) peptide, thought to be a key mediator of AD, coordinately increase neuronal Ca2+ and nitric oxide (NO) in an NMDA receptor-dependent manner. The increase in NO results in S-nitrosylation of insulin-degrading enzyme (IDE) and dynamin-related protein 1 (Drp1), thus inhibiting insulin and Aβ catabolism as well as hyperactivating mitochondrial fission machinery. Consequent elevation in Aβ levels and compromise in mitochondrial bioenergetics result in dysfunctional synaptic plasticity and synapse loss in cortical and hippocampal neurons. The NMDA receptor antagonist memantine attenuates these effects. Our studies show that redox-mediated posttranslational modification of brain proteins link Aβ and hyperglycaemia to cognitive dysfunction in MetS/T2DM and AD.
Alzheimer's disease is linked to metabolic syndrome and Type-2 diabetes, but the mechanism behind this association is unclear. Here, the authors show that elevated glucose and amyloid ß work together to increase nitrosative stress, leading to aberrant mitochondrial activity and synaptic dysfunction.
Databáze: OpenAIRE